PV22 PRECONFERENCE WORKSHOP
A Digital Transformation in Haemato-Oncology: The First Full-Field Bone Marrow Aspirate™ Analysis Platform
Current methods for the analysis and reporting of bone marrow aspirate (BMA) specimens are based on manual microscopy making them prone to intra- or inter- reviewer variability. The lack of uniformity can lead to inconsistencies in disease diagnosis and classification, thereby affecting treatment and clinical outcomes. Considering the complexity of the manual BMA analysis, especially in routine laboratory settings with demanding turnaround times, a digital transformation can sustain the desired standardization, increased sensitivity, and efficiency in routine workflow.
We will demonstrate the value in digital monitoring of patients with hematologic malignancies, harnessing the power of AI-based Decision Support to augment the work of haematopathologists and haemato-oncologists. Scopio’s Full- Field Bone Marrow AspirateTM Application, the first digital cell morphology application that enables a complete digital workflow for a BMA review, is CE-marked.